Hengrui Pharmaceutical announced that as of October 31, 2026, the company's share repurchase plan had a total of 1,636,200 A-shares through the Shanghai Stock Exchange trading system. The repurchased shares accounted for 0.025% of the company's total share capital. The highest purchase price was RMB 46.33 yuan/share, the lowest price was RMB 43.10 yuan/share, and the total amount paid was RMB 73.8849 million. The above repurchases comply with the relevant laws and regulations and the company's established share repurchase plan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.